论文部分内容阅读
1991年,美国219个移植中心进行了9943例肾移植(其中7737例为尸体肾移植,2206例为活体肾移植),虽然年总数几乎是10年前的2倍,并且保持相对稳定,但远远不能与当今终末期肾衰(ESRD)患者增加的数量相适应,由于能得到的供肾不能相应的增加,而每年等待肾移植的患者又在持续地增加,使得大多数患者要等1年以上才能得到供肾。作为临床肾脏病学家,我们应该向ESRD患者推荐最好的治疗方式。90年代,我们对肾移植有何看法?它是不是比透析更好?在一些具有特别危险因素的患者中,如糖尿病、高龄患者和美国黑人,能取得什么样的结果?在下面的综述中,将论述这些问题,并且对当今肾移植争论较激烈的一些问题进行讨论。
In 1991, 9,993 kidney transplants were carried out in 219 transplant centers in the United States (of which 7,737 were cadaveric kidney transplants and 2,206 were live donor kidney transplants). Although the total annual number was almost double that of 10 years ago and remained relatively stable Far from being compatible with the increased numbers of patients with end-stage renal failure (ESRD) today, and the number of patients awaiting kidney transplants continues to increase each year due to a corresponding increase in available kidneys, leaving most patients to wait one year Above can get the kidney. As a clinical nephrologist, we recommend the best treatment for ESRD patients. What do we think of kidney transplantation in the 1990s? Is it better than dialysis? What can be achieved in some patients with special risk factors, such as diabetes, elderly patients and Afro-Americans? In the following review , Will address these issues and discuss some of the more debatable topics in today’s kidney transplant.